Skip to main content
SpringerLink
Log in

Epidemiology, Staging, and Screening of Head and Neck Cancer

  • Chapter
Head and Neck Cancer

Part of the book series: Cancer Treatment and Research ((CTAR,volume 114))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics, 2001. CA Cancer J Clin 2001; 51:15–36.

    PubMed  CAS  Google Scholar 

  2. Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J Clin 1999; 49:33–64, 1.

    PubMed  CAS  Google Scholar 

  3. Skarsgard DP, Groome PA, Mackillop WJ, et al. Cancers of the upper aerodigestive tract in Ontario, Canada, and the United States. Cancer 2000; 88:1728–38.

    Article  PubMed  CAS  Google Scholar 

  4. Vokes EE, Liebowitz DN, Weichselbaum RR. Nasopharyngeal carcinoma. Lancet 1997; 350:1087–91.

    PubMed  CAS  Google Scholar 

  5. Franceschi S, Bidoli E, Herrero R, Munoz N. Comparison of cancers of the oral cavity and pharynx worldwide: etiological clues. Oral Oncol 2000; 36:106–15.

    Article  PubMed  CAS  Google Scholar 

  6. Llewellyn CD, Johnson NW, Warnakulasuriya KA. Risk factors for squamous cell carcinoma of the oral cavity in young people a comprehensive literature review. Oral Oncol 2001; 37:401–18.

    Article  PubMed  CAS  Google Scholar 

  7. Ries LAG, Eisner MP, Kosary CL, et al. SEER Cancer Statistics Review, 1973 1998, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/publications/CSR1973_1998/,2001.

    Google Scholar 

  8. Brugere J, Guenel P, Leclerc A, Rodriguez J. Differential effects of tobacco and alcohol in cancer of the larynx, pharynx, and mouth. Cancer 1986; 57:391–5.

    PubMed  CAS  Google Scholar 

  9. Day GL, Blot WJ, Austin DF, et al. Racial differences in risk of oral and pharyngeal cancer: alcohol, tobacco, and other determinants. J Natl Cancer Inst 1993; 85:465–73.

    PubMed  CAS  Google Scholar 

  10. Thorne P, Etherington D, Birchall MA. Head and neck cancer in the South West of England: influence of socio economic status on incidence and second primary tumours. Eur J Surg Oncol 1997; 23:503–8.

    Article  PubMed  CAS  Google Scholar 

  11. Williams RR, Horm JW. Association of cancer sites with tobacco and alcohol consumption and socioeconomic status of patients: interview study from the Third National Cancer Survey. J Natl Cancer Inst 1977; 58:525–47.

    PubMed  CAS  Google Scholar 

  12. Mackillop WJ, Zhang Salomons J, Boyd CJ, Groome PA. Associations between community income and cancer incidence in Canada and the United States. Cancer 2000; 89:901–12.

    Article  PubMed  CAS  Google Scholar 

  13. Elwood JM, Pearson JC, Skippen DH, Jackson SM. Alcohol, smoking, social and occupational factors in the aetiology of cancer of the oral cavity, pharynx and larynx. Int J Cancer 1984; 34:603–12.

    PubMed  CAS  Google Scholar 

  14. Greeberg RS, Haber MJ, Clark WS, et al. The relation of socioeconomic status to oral and pharyngeal cancer. Epidemiology 1991; 2:194–200.

    Google Scholar 

  15. Wynder EL, Bross IJ, Feldman RM. A study of etiological factors in cancer of the mouth. Cancer 1957; 10:1300–23.

    PubMed  CAS  Google Scholar 

  16. Blot WJ, McLaughlin JK, Winn DM, et al. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res 1988; 48:3282–7.

    PubMed  CAS  Google Scholar 

  17. Tuyns AJ, Esteve J, Raymond L, et al. Cancer of the larynx/hypopharynx, tobacco and alcohol: IARC international case-control study in Turin and Varese (Italy), Zaragoza and Navarra (Spain), Geneva (Switzerland) and Calvados (France). Int J Cancer 1988; 41:483–91.

    PubMed  CAS  Google Scholar 

  18. Franceschi S, Talamini R, Barra S, et al. Smoking and drinking in relation to cancers of the oral cavity, pharynx, larynx, and esophagus in northern Italy. Cancer Res 1990; 50:6502–7.

    PubMed  CAS  Google Scholar 

  19. Mashberg A, Boffetta P, Winkelman R, Garfinkel L. Tobacco smoking, alcohol drinking, and cancer of the oral cavity and oropharynx among U.S. veterans. Cancer 1993; 72:1369–75.

    PubMed  CAS  Google Scholar 

  20. Franco EL, Kowalski LP, Oliveira BV, et al. Risk factors for oral cancer in Brazil: a case-control study. Int J Cancer 1989; 43:992–1000.

    PubMed  CAS  Google Scholar 

  21. Zheng TZ, Boyle P, Hu HF, et al. Tobacco smoking, alcohol consumption, and risk of oral cancer: a case control study in Beijing, People’s Republic of China. Cancer Causes Control 1990; 1:173–9.

    PubMed  CAS  Google Scholar 

  22. Macfarlane GJ, Zheng T, Marshall JR, et al. Alcohol, tobacco, diet and the risk of oral cancer: a pooled analysis of three case-control studies. Eur J Cancer B Oral Oncol 1995; 31B:181–7.

    PubMed  CAS  Google Scholar 

  23. Bundgaard T, Wildt J, Frydeberg M, Elbrond O, Nielsen JE. Case-control study of squamous cell cancer of the oral cavity in Denmark. Cancer Causes Control 1995; 6:57–67.

    Article  PubMed  CAS  Google Scholar 

  24. Andre K, Schraub S, Mercier M, Bontemps P. Role of alcohol and tobacco in the aetiology of head and neck cancer: a case-control study in the Doubs region of France. Eur J Cancer B Oral Oncol 1995; 31B:301–9.

    PubMed  CAS  Google Scholar 

  25. Lewin F, Norell SE, Johansson H, et al. Smoking tobacco, oral snuff, and alcohol in the etiology of squamous cell carcinoma of the head and neck: a population based case referent study in Sweden. Cancer 1998; 82:1367–75.

    Article  PubMed  CAS  Google Scholar 

  26. Kjaerheim K, Gaard M, Andersen A. The role of alcohol, tobacco, and dietary factors in upper aerogastric tract cancers: a prospective study of 10,900 Norwegian men. Cancer Causes Control 1998; 9:99–108.

    PubMed  CAS  Google Scholar 

  27. Enstrom JE. Cancer mortality among Mormons. Cancer 1975; 36:825–41.

    PubMed  CAS  Google Scholar 

  28. Phillips RL, Garfinkel L, Kuzma JW, Beeson WL, Lotz T, Brin B. Mortality among California Seventh Day Adventists for selected cancer sites. J Natl Cancer Inst 1980; 65:1097–1107.

    PubMed  CAS  Google Scholar 

  29. Baden E. Prevention of cancer of the oral cavity and pharynx. CA Cancer J Clin 1987; 37:49–62.

    PubMed  CAS  Google Scholar 

  30. State specific prevalence of current cigarette smoking among adults, and policies and attitudes about secondhand smoke united States, 2000. MMWR 2001; 50:1101–6.

    Google Scholar 

  31. Hecht SS. Tobacco smoke carcinogens and lungcancer. J Natl Cancer Inst 1999; 91:1194–210.

    Article  PubMed  CAS  Google Scholar 

  32. Spitz MR, Fueger JJ, Goepfert H, Hong WK, Newell GR. Squamous cell carcinoma of the upper aerodigestive tract. A case comparison analysis. Cancer 1988; 61:203–8.

    PubMed  CAS  Google Scholar 

  33. Wynder EL, Stellman SD. Impact of long term filter cigarette usage on lung and larynx cancer risk: a case-control study. J Natl Cancer Inst 1979; 62:471–7.

    PubMed  CAS  Google Scholar 

  34. Wynder EL, Stellman SD. Comparative epidemiology of tobacco related cancers. Cancer Res 1977; 37:4608–22.

    PubMed  CAS  Google Scholar 

  35. Moore C. Cigarette smoking and cancer of the mouth, pharynx, and larynx. A continuing study. Jama 1971; 218:553–8.

    PubMed  CAS  Google Scholar 

  36. Silverman S, Jr., Griffith M.Smoking characteristics of patients with oral carcinoma and the risk for second oral primary carcinoma. J Am Dent Assoc 1972; 85:637–40.

    PubMed  Google Scholar 

  37. Ostroff JS, Jacobsen PB, Moadel AB, et al. Prevalence and predictors of continued tobacco use after treatment of patients with head and neck cancer. Cancer 1995; 75:569–76.

    PubMed  CAS  Google Scholar 

  38. Gritz ER, Carr CR, Rapkin D, et al. Predictors of long term smoking cessation in head and neck cancer patients. Cancer Epidemiol Biomarkers Prev 1993; 2:261–70.

    PubMed  CAS  Google Scholar 

  39. Browman GP, Wong G, Hodson I, et al. Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. N Engl J Med 1993; 328:159–63.

    Article  PubMed  CAS  Google Scholar 

  40. Acetaldehyde. IARC Monogr Eval Carcinog Risk Chem Hum 1985; 36:101–32.

    Google Scholar 

  41. Fioretti F, Bosetti C, Tavani A, Franceschi S, La Vecchia C. Risk factors for oral and pharyngeal cancer in never smokers. Oral Oncol 1999; 35:375–8.

    Article  PubMed  CAS  Google Scholar 

  42. Barra S, Franceschi S, Negri E, Talamini R, La Vecchia C. Type of alcoholic beverage and cancer of the oral cavity, pharynx and oesophagus in an Italian area with high wine consumption. Int J Cancer 1990; 46:1017–20.

    PubMed  CAS  Google Scholar 

  43. Kabat GC, Wynder EL. Type of alcoholic beverage and oral cancer. Int J Cancer 1989; 43:190–4.

    PubMed  CAS  Google Scholar 

  44. Satcher D. Cigars and public health. N Engl J Med 1999; 340:1829–31.

    Article  PubMed  CAS  Google Scholar 

  45. Iribarren C, Tekawa IS, Sidney S, Friedman GD. Effect of cigar smoking on the risk of cardiovascular disease, chronic obstructive pulmonary disease, and cancer in men. N Engl J Med 1999; 340:1773–80.

    Article  PubMed  CAS  Google Scholar 

  46. Connolly GN, Winn DM, Hecht SS, Henningfield JE, Walker B, Jr., Hoffmann D. The reemergence of smokeless tobacco. N Engl J Med 1986; 314:1020–7.

    Article  PubMed  CAS  Google Scholar 

  47. Winn DM, Blot WJ, Shy CM, Pickle LW, Toledo A, Fraumeni JF, Jr. Snuff dipping and oral cancer among women in the southern United States. N Engl J Med 1981; 304:745–9.

    Article  PubMed  CAS  Google Scholar 

  48. Silverman S. Oral Cancer. In: Silverman S, ed. Atlanta: The American Cancer Society, 1990.

    Google Scholar 

  49. Jussawalla DJ, Deshpande VA. Evaluation of cancer risk in tobacco chewers and smokers: an epidemiologic assessment. Cancer 1971; 28:244–52.

    PubMed  CAS  Google Scholar 

  50. Hodge KM, Flynn MB, Drury T. Squamous cell carcinoma of the upper aerodigestive tract in nonusers of tobacco. Cancer 1985; 55:1232–5.

    PubMed  CAS  Google Scholar 

  51. Ng SK, Kabat GC, Wynder EL. Oral cavity cancer in non-users of tobacco. J Natl Cancer Inst 1993; 85:743–5.

    PubMed  CAS  Google Scholar 

  52. Koch WM, Lango M, Sewell D, Zahurak M, Sidransky D. Head and neck cancer in nonsmokers: a distinct clinical and molecular entity. Laryngoscope 1999; 109:1544–51.

    PubMed  CAS  Google Scholar 

  53. Schantz SP, Byers RM, Goepfert H, Shallenberger RC, Beddingfield N. The implication of tobacco use in the young adult with head and neck cancer. Cancer 1988; 62:1374–80.

    PubMed  CAS  Google Scholar 

  54. Brennan JA, Boyle JO, Koch WM, et al. Association between cigarette smoking and mutation of the p53 gene in squamous cell carcinoma of the head and neck. N Engl J Med 1995; 332:712–7.

    PubMed  CAS  Google Scholar 

  55. Hoffman D, Brunnemann DX, Gori GB, Wynder EL. On the carcinogenicity of marijuana smoke. Recent Adv. Phytochem., 1975; 9:63–81.

    Google Scholar 

  56. Wu TC, Tashkin DP, Djahed B, Rose JE. Pulmonary hazards of smoking marijuana as compared with tobacco. N Engl J Med 1988; 318:347–51.

    Article  PubMed  CAS  Google Scholar 

  57. Zhang ZF, Morgenstern H, Spitz MR, et al. Marijuana use and increased risk of squamous cell carcinoma of the head and neck. Cancer Epidemiol Biomarkers Prev 1999; 8:1071–8.

    PubMed  CAS  Google Scholar 

  58. Burch JD, Howe GR, Miller AB, Semenciw R. Tobacco, alcohol, asbestos, and nickel in the etiology of cancer of the larynx: a case control study. J Natl Cancer Inst 1981; 67:1219–24.

    PubMed  CAS  Google Scholar 

  59. Rothman KJ, Cann CI, Flanders D, Fried MP. Epidemiology of laryngeal cancer. Epidemiol Rev 1980; 2:195–209.

    PubMed  CAS  Google Scholar 

  60. Gustavsson P, Jakobsson R, Johansson H, Lewin F, Norell S, Rutkvist LE. Occupational exposures and squamous cell carcinoma of the oral cavity, pharynx, larynx, and oesophagus: a case-control study in Sweden. Occup Environ Med 1998; 55:393–400.

    PubMed  CAS  Google Scholar 

  61. IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans, International Agency for Research on Cancer Working Group. Wood dust and formaldehyde, Lyon, France, 1995.

    Google Scholar 

  62. Blair A, Stewart P, O’Berg M, et al. Mortality among industrial workers exposed to formaldehyde. J Natl Cancer Inst 1986; 76:1071–84.

    PubMed  CAS  Google Scholar 

  63. Blair A, Saracci R, Stewart PA, Hayes RB, Shy C. Epidemiologic evidence on the relationship between formaldehyde exposure and cancer. Scand J Work Environ Health 1990; 16:381–93.

    PubMed  CAS  Google Scholar 

  64. Roush GC, Walrath J, Stayner LT, Kaplan SA, Flannery JT, Blair A. Nasopharyngeal cancer, sinonasal cancer, and occupations related to formaldehyde: a case-control study. J Natl Cancer Inst 1987; 79:1221–4.

    PubMed  CAS  Google Scholar 

  65. West S, Hildesheim A, Dosemeci M. Non-viral risk factors for nasopharyngeal carcinoma in the Philippines: results from a case control study. Int J Cancer 1993; 55:722–7.

    PubMed  CAS  Google Scholar 

  66. Vaughan TL, Strader C, Davis S, Daling JR. Formaldehyde and cancers of the pharynx, sinus and nasal cavity: II. Residential exposures. Int J Cancer 1986; 38:685–8.

    PubMed  CAS  Google Scholar 

  67. Armstrong RW, Imrey PB, Lye MS, Armstrong MJ, Yu MC, Sani S. Nasopharyngeal carcinoma in Malaysian Chinese: occupational exposures to particles, formaldehyde and heat. Int J Epidemiol 2000; 29:991–8.

    Article  PubMed  CAS  Google Scholar 

  68. Demers PA, Kogevinas M, Boffetta P, et al. Wood dust and sino-nasal cancer: pooled reanalysis of twelve case-control studies. Am J Ind Med 1995; 28:151–66.

    PubMed  CAS  Google Scholar 

  69. Cecchi F, Buiatti E, Kriebel D, Nastasi L, Santucci M. Adenocarcinoma of the nose and paranasal sinuses in shoemakers and woodworkers in the province of Florence, Italy (1963–77). Br J Ind Med 1980; 37:222–5.

    PubMed  CAS  Google Scholar 

  70. Hayes RB, Gerin M, Raatgever JW, de Bruyn A. Wood-related occupations, wood dust exposure, and sinonasal cancer. Am J Epidemiol 1986; 124:569–77.

    PubMed  CAS  Google Scholar 

  71. Brinton LA, Blot WJ, Becker JA, et al. A case-control study of cancers of the nasal cavity and paranasal sinuses. Am J Epidemiol 1984; 119:896–906.

    PubMed  CAS  Google Scholar 

  72. Zhang ZF, Morgenstern H, Spitz MR, et al. Environmental tobacco smoking, mutagen sensitivity, and head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 2000; 9:1043–9.

    PubMed  CAS  Google Scholar 

  73. McLaughlin JK, Gridley G, Block G, et al. Dietary factors in oral and pharyngeal cancer. J Natl Cancer Inst 1988; 80:1237–43.

    PubMed  CAS  Google Scholar 

  74. Zheng W, Blot WJ, Shu XO, et al. Risk factors for oral and pharyngeal cancer in Shanghai, with emphasis on diet. Cancer Epidemiol Biomarkers Prev 1992; 1:441–8.

    PubMed  CAS  Google Scholar 

  75. Riboli E, Kaaks R, Esteve J. Nutrition and laryngeal cancer. Cancer Causes Control 1996; 7:147–56.

    Article  PubMed  CAS  Google Scholar 

  76. de Visscher JG, van der Waal I. Etiology of cancer of the lip. A review. Int J Oral Maxillofac Surg 1998; 27:199–203.

    PubMed  Google Scholar 

  77. Maier H, Zoller J, Herrmann A, Kreiss M, Heller WD. Dental status and oral hygiene in patients with head and neck cancer. Otolaryngol Head Neck Surg 1993; 108:655–61.

    PubMed  CAS  Google Scholar 

  78. Marshall JR, Graham S, Haughey BP, et al. Smoking, alcohol, dentition and diet in the epidemiology of oral cancer. Eur J Cancer B Oral Oncol 1992; 28B:9–15.

    PubMed  CAS  Google Scholar 

  79. Winn DM, Blot WJ, McLaughlin JK, et al. Mouthwash use and oral conditions in the risk of oral and pharyngeal cancer. Cancer Res 1991; 51:3044–7.

    PubMed  CAS  Google Scholar 

  80. Velly AM, Franco EL, Schlecht N, et al. Relationship between dental factors and risk of upper aerodgestive tract cancer. Oral Oncol 1998; 34:284–91.

    Article  PubMed  CAS  Google Scholar 

  81. Mashberg A, Barsa P, Grossman ML. A study of the relationship between mouthwash use and oral and pharyngeal cancer. J Am Dent Assoc 1985; 110:731–4.

    PubMed  CAS  Google Scholar 

  82. Young TB, Ford CN, Brandenburg JH. An epidemiologic study of oral cancer in a statewide network. Am J Otolaryngol 1986; 7:200–8.

    PubMed  CAS  Google Scholar 

  83. Seymour RA, Thomason JM, Nolan A. Oral lesions in organ transplant patients. J Oral Pathol Med 1997; 26:297–304.

    PubMed  CAS  Google Scholar 

  84. Lippman SM, Hong WK. Molecular markers of the risk of oral cancer. N Engl J Med 2001; 344:1323–6.

    Article  PubMed  CAS  Google Scholar 

  85. Banoczy J, Gintner Z, Dombi C. Tobacco use and oral leukoplakia. J Dent Educ 2001; 65:322–7.

    PubMed  CAS  Google Scholar 

  86. Lippman SM, Hong WK. Second malignant tumors in head and neck squamous cell carcinoma: the overshadowing threat for patients with early-stage disease. Int J Radiat Oncol Biol Phys 1989; 17:691–4.

    PubMed  CAS  Google Scholar 

  87. Mashberg A, Morrissey JB, Garfinkel L. A study of the appearance of early asymptomatic oral squamous cell carcinoma. Cancer 1973; 32:1436–45.

    PubMed  CAS  Google Scholar 

  88. Franceschi S, Munoz N, Bosch XF, Snijders PJ, Walboomers JM. Human papillomavirus and cancers of the upper aerodigestive tract: a review of epidemiological and experimental evidence. Cancer Epidemiol Biomarkers Prev 1996;5:567–75.

    PubMed  CAS  Google Scholar 

  89. McKaig RG, Baric RS, Olshan AF. Human papillomavirus and head and neck cancer: epidemiology and molecular biology. Head Neck 1998;20:250–65.

    Article  PubMed  CAS  Google Scholar 

  90. Hemminski K, Dong C, Frisch M. Tonsillar and other upper aerodigestive tract cancers among cervical cancer patients and their husbands. Eur J Cancer Prev 2000; 9:433–437.

    Google Scholar 

  91. Frisch M, Bggar RJ. Aetiological parallel between tonsillar and anogenital squamous-cell carcinomas. Lancet 1999;354:1442–3.

    Article  PubMed  CAS  Google Scholar 

  92. Frisch M, Biggar RJ, Goedert JJ. Human papillomavirus associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst 2000; 92:1500–10.

    Article  PubMed  CAS  Google Scholar 

  93. Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000; 92:709–20.

    Article  PubMed  CAS  Google Scholar 

  94. Mellin H, Friesland S, Lewensohn R, Dalianis T, Munck-Wikland E. Human papillomavirus (HPV) DNA in tonsillar cancer: clinical correlates, risk of relapse, and survival. Int J Cancer 2000; 89:300–4.

    Article  PubMed  CAS  Google Scholar 

  95. Brandsma JL, Abramson AL. Association of papillomavirus with cancers of the head and neck. Arch Otolaryngol Head Neck Surg 1989; 115:621–5.

    PubMed  CAS  Google Scholar 

  96. Maden C, Beckmann AM, Thomas DB, et al. Human papillomaviruses, herpes simplex viruses, and the risk of oral cancer in men. Am J Epidemiol 1992; 135:1093–102.

    PubMed  CAS  Google Scholar 

  97. Smith EM, Hoffman HT, Summersgill KS, Kirchner HL, Turek LP, Haugen TH. Human papillomavirus and risk of oral cancer. Laryngoscope 1998; 108:1098–103.

    PubMed  CAS  Google Scholar 

  98. Schwartz SM, Daling JR, Doody DR, et al. Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J Natl Cancer Inst 1998; 90:1626–36.

    Article  PubMed  CAS  Google Scholar 

  99. Mork J, Lie AK, Glattre E, et al. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl JMed 2001; 344:1125–31.

    CAS  Google Scholar 

  100. Ho JH. An epidemiologic and clinical study of nasopharyngeal carcinoma, Int J Radial Oncol Biol Phys 1978; 4:182–98.

    CAS  Google Scholar 

  101. Liebowitz D. Nasopharyngeal carcinoma: the Epstein-Barr virus association. Semin Oncol 1994; 21:376–81.

    PubMed  CAS  Google Scholar 

  102. Yu MC. Diet and nasopharyngeal carcinoma. Prog Clin Biol Res 1990; 346:93–105.

    PubMed  CAS  Google Scholar 

  103. Buell P. The effect of migration on the risk of nasopharyngeal cancer among Chinese. Cancer Res 1974; 34:1189–91.

    PubMed  CAS  Google Scholar 

  104. Fremgen AM, Bland KI, McGinnis LS, Jr., et al. Clinical highlights from the National Cancer Data Base, 1999. CA Cancer J Clin 1999; 49:145–58.

    Article  PubMed  CAS  Google Scholar 

  105. Armstrong RW, Armstrong MJ, Yu MC, Henderson BE. Salted fish and inhalants as risk factors for nasopharyngeal carcinoma in Malaysian Chinese. Cancer Res 1983; 43:2967–70.

    PubMed  CAS  Google Scholar 

  106. Yu MC, Ho JH, Henderson BE, Armstrong RW. Epidemiology of nasopharyngeal carcinoma in Malaysia and Hong Kong. Natl Cancer List Monogr 1985; 69:203–7.

    CAS  Google Scholar 

  107. Yu MC, Ho JH, Lai SH, Henderson BE. Cantonese-style salted fish as a cause of nasopharyngeal carcinoma: report of a case-control study in Hong Kong. Cancer Res 1986; 46:956–61.

    PubMed  CAS  Google Scholar 

  108. Yu MC, Huang TB, Henderson BE. Diet and nasopharyngeal carcinoma: a case-control study in Guangzhou, China, hit J Cancer 1989; 43.1077–82.

    CAS  Google Scholar 

  109. Yu MC, Mo CC, Chong WX, Yeh FS, Henderson BE. Preserved foods and nasopharyngeal carcinoma: a case-control study in Guangxi, China. Cancer Res 1988; 48:1954–9.

    PubMed  CAS  Google Scholar 

  110. Zheng YM, Tuppin P, Hubert A, et al. Environmental and dietary risk factors for nasopharyngeal carcinoma: a case-control study in Zangwu County, Guangxi, China. Br J Cancer 1994; 69:508–14.

    PubMed  CAS  Google Scholar 

  111. Ning JP, Yu MC, Wang QS, Henderson BE. Consumption of salted fish and other risk factors for nasopharyngeal carcinoma (NPC) in Tianjin, a low-risk region for NPC in the People’s Republic of China. J Natl Cancer Inst 1990; 82:291–6.

    PubMed  CAS  Google Scholar 

  112. Lee HP, Gourley L, Duffy SW, Esteve J, Lee J, Day NE. Preserved foods and nasopharyngeal carcinoma: a case-control study among Singapore Chinese. Int J Cancer 1994; 59:585–90.

    PubMed  CAS  Google Scholar 

  113. Simons MJ, Wee GB, Goh EH, et al. Immunogenetic aspects of nasopharyngeal carcinoma. IV. Increased risk in Chinese of nasopharyngeal carcinoma associated with a Chinese-related HLA profile (A2, Singapore 2). J Natl Cancer Inst 1976; 57:977–80.

    PubMed  CAS  Google Scholar 

  114. Lu SJ, Day NE, Degos L, et al. Linkage of a nasopharyngeal carcinoma susceptibility locus to the HLA region. Nature 1990; 346:470–1.

    Article  PubMed  CAS  Google Scholar 

  115. Henderson BE, Louie E, SooHoo Jing J, Buell P, Gardner MB. Risk factors associated with nasopharyngeal carcinoma. N Engl JMed 1976; 295:1101–6.

    Article  CAS  Google Scholar 

  116. Chow WH, McLaughlin JK, Hrubec Z, Nam JM, Blot WJ. Tobacco use and nasopharyngeal carcinoma in a cohort ofUS veterans. Int J Cancer 1993; 55:538–40.

    PubMed  CAS  Google Scholar 

  117. Nam JM, McLaughlin JK, Blot WJ. Cigarette smoking, alcohol, and nasopharyngeal carcinoma: a case-control study among U.S. whites. JNatl Cancer Inst 1992; 84:619–22.

    CAS  Google Scholar 

  118. Lin TM, Chang HJ, Chen CJ, et al. Risk factors for nasopharyngeal carcinoma. Anticancer Res 1986; 6:791–6.

    PubMed  CAS  Google Scholar 

  119. Yu MC, Garabrant DH, Huang TB, Henderson BE. Occupational and other nondietary risk factors for nasopharyngeal carcinoma in Guangzhou, China. Int J Cancer 1990; 45:1033–9.

    PubMed  CAS  Google Scholar 

  120. Vaughan TL, Shapiro JA, Burt RD, et al. Nasopharyngeal cancer in a low-risk population: defining risk factors by histological type. Cancer Epidemiol Biomarkers Prev 1996; 5:587–93.

    PubMed  CAS  Google Scholar 

  121. Hildesheim A, Anderson LM, Chen CJ, et al. CYP2E1 genetic polymorphisms and risk of nasopharyngeal carcinoma in Taiwan. J Natl Cancer Inst 1997; 89:1207–12.

    PubMed  CAS  Google Scholar 

  122. Nazar-Stewart V, Vaughan TL, Burt RD, Chen C, Berwick M, Swanson GM. Glutathione S-transferase Ml and susceptibility to nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev 1999; 8:547–51.

    PubMed  CAS  Google Scholar 

  123. Old LH, Boyse EA, Oettgen HF. Precipitation antibody in human serum to an antigen present in cultured Burkitt’s lymphoma cells. Proc Natl Acad Sci USA 1966; 56:1699–704.

    CAS  PubMed  Google Scholar 

  124. Wolf H, zur Hausen H, Becker V. EB viral genomes in epithelial nasopharyngeal carcinoma cells. Nat New Biol 1973; 244:245–7.

    PubMed  CAS  Google Scholar 

  125. Andersson-Anvret M, Forsby N, Klein G, Henle W. Relationship between the Epstein-Barr virus and undifferentiated nasopharyngeal carcinoma: correlated nucleic acid hybridization and histopathological examination. Int J Cancer 1977; 20:486–94.

    Article  PubMed  CAS  Google Scholar 

  126. Hording U, Nielsen HW, Albeck H, Daugaard S. Nasopharyngeal carcinoma: histopathological types and association with Epstein-Barr Virus. Eur J Cancer B Oral Oncol 1993; 29B: 137–9.

    PubMed  CAS  Google Scholar 

  127. Walter MA, Menarguez-Palanca J, Peiper SC. Epstein-Barr virus detection in neck metastases by polymerase chain reaction. Laryngoscope 1992; 102:481–5.

    PubMed  CAS  Google Scholar 

  128. Tsai ST, Jin YT, Su IJ. Expression of EBER1 in primary and metastatic nasopharyngeal carcinoma tissues using in situ hybridization. A correlation with WHO histologic subtypes. Cancer 1996; 77:231–6.

    Article  PubMed  CAS  Google Scholar 

  129. Wu TC, Mann RB, Epstein JI, et al. Abundant expression of EBER1 small nuclear RNA in nasopharyngeal carcinoma. A morphologically distinctive target for detection of Epstein-Barr virus in formalin-fixed paraffin-embedded carcinoma specimens. Am J Pathol 1991; 138:1461–9.

    PubMed  CAS  Google Scholar 

  130. Lee WY, Hsiao JR, Jin YT, Tsai ST. Epstein-Barr virus detection in neck metastases by in-situ hybridization in fine-needle aspiration cytologic studies: an aid for differentiating the primary site. Head Neck 2000; 22:336–40.

    Article  PubMed  CAS  Google Scholar 

  131. Lo YM, Chan LY, Lo KW, et al. Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma. Cancer Res 1999; 59:1188–91.

    PubMed  CAS  Google Scholar 

  132. Lo YM, Chan LY, Chan AT, et al. Quantitative and temporal correlation between circulating cell-free Epstein-Barr virus DNA and tumor recurrence in nasopharyngeal carcinoma. Cancer Res 1999; 59:5452–5.

    PubMed  CAS  Google Scholar 

  133. Shotelersuk K, Khorprasert C, Sakdikul S, Pomthanakasem W, Voravud N, Mutirangura A. Epstein-Barr virus DNA in serum/plasma as a tumor marker for nasopharyngeal cancer. Clin Cancer Res 2000; 6:1046–51.

    PubMed  CAS  Google Scholar 

  134. Lin JC, Chen KY, Wang WY, et al. Detection of Epstein-Barr virus DNA the peripheral-blood cells of patients with nasopharyngeal carcinoma: relationship to distant metastasis and survival. J Clin Oncol 2001; 19:2607–15.

    PubMed  CAS  Google Scholar 

  135. Henle G, Henle W. Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma. Int J Cancer 1976; 17:1–7.

    PubMed  CAS  Google Scholar 

  136. Neel HB, 3rd, Pearson GR, Weiland LH, et al. Application of Epstein-Barr virus serology to the diagnosis and staging of North American patients with nasopharyngeal carcinoma. Otolaryngol Head Neck Surg 1983; 91:255–62.

    PubMed  Google Scholar 

  137. Pearson GR, Weiland LH, Neel HB, 3rd, et al. Application of Epstein-Barr virus (EBV) serology to the diagnosis of North American nasopharyngeal carcinoma. Cancer 1983; 51:260–8.

    PubMed  CAS  Google Scholar 

  138. Chien YC, Chen JY, Liu MY, et al. Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Tawanese men. N Engl JMed 2001; 345:1877–82.

    CAS  Google Scholar 

  139. Zeng Y, Zhang LG, Li HY, et al. Serological mass survey for early detection of nasopharyngeal carcinoma in Wuzhou City, China. Int J Cancer 1982; 29:139–41.

    PubMed  CAS  Google Scholar 

  140. Zeng Y, Zhong JM, Li LY, et al. Follow-up studies on Epstein-Barr virus IgA/VCA antibody-positive persons in Zangwu County, China. Intervirology 1983; 20:190–4.

    Article  PubMed  CAS  Google Scholar 

  141. Kassim KH, Daley TD. Herpes simplex virus type 1 proteins in human oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol 1988; 65:445–8.

    Article  PubMed  CAS  Google Scholar 

  142. Shillitoe EJ, Greenspan D, Greenspan JS, Silverman S, Jr. Five-year survival of patients with oral cancer and its association with antibody to herpes simplex virus. Cancer 1986; 58:2256–9.

    PubMed  CAS  Google Scholar 

  143. Califano J, van der Riet P, Westra W, et al. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 1996; 56:2488–92.

    PubMed  CAS  Google Scholar 

  144. Copper MP, Jovanovic A, Nauta JJ, et al. Role of genetic factors in the etiology of squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 1995; 121:157–60.

    PubMed  CAS  Google Scholar 

  145. Foulkes WD, Brunet JS, Sieh W, Black MJ, Shenouda G, Narod SA. Familial risks of squamous cell carcinoma of the head and neck: retrospective case-control study. Bmj 1996; 313:716–21.

    PubMed  CAS  Google Scholar 

  146. Trizna Z, Schantz SP. Hereditary and environmental factors associated with risk and progression of head and neck cancer. Otolaryngol Clin North Am 1992; 25:1089–103.

    PubMed  CAS  Google Scholar 

  147. Lazarus P, Park JY. Metabolizing enzyme genotype and risk for upper aerodigestive tract cancer. Oral Oncol 2000; 36:421–31.

    Article  PubMed  CAS  Google Scholar 

  148. Rebbeck TR. Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomarkers Prev 1997; 6:733–43.

    PubMed  CAS  Google Scholar 

  149. Goedde HW, Agarwal DP, Fritze G, et al. Distribution of ADH2 and ALDH2 genotypes in different populations. Hum Genet 1992; 88:344–6.

    Article  PubMed  CAS  Google Scholar 

  150. Bartsch H, Nair U, Risch A, Rojas M, Wikman H, Alexandrov K. Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. Cancer Epidemiol Biomarkers Prev 2000; 9:3–28.

    PubMed  CAS  Google Scholar 

  151. Oude Ophuis MB, van Lieshout EM, Roelofs HM, Peters WH, Manni JJ. Glutathione S-transferase M1 and T1 and cytochrome P4501A1 polymorphisms in relation to the risk for benign and malignant head and neck lesions. Cancer 1998; 82:936–43.

    PubMed  CAS  Google Scholar 

  152. Lucas D, Menez C, Floch F, et al. Cytochromes P4502E1 and P4501A1 genotypes and susceptibility to cirrhosis or upper aerodigestive tract cancer in alcoholic Caucasians. Alcohol Clin Exp Res 1996; 20:1033–7.

    PubMed  CAS  Google Scholar 

  153. Matthias C, Bockmuhl U, Jahnke V, et al. Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: studies in upper aerodigestive tract cancers. Pharmacogenetics 1998; 8:91–100.

    PubMed  CAS  Google Scholar 

  154. Katoh T, Kaneko S, Kohshi K, et al. Genetic polymorphisms of tobacco-and alcohol-related metabolizing enzymes and oral cavity cancer. Int J Cancer 1999; 83:606–9.

    Article  PubMed  CAS  Google Scholar 

  155. Morita S, Yano M, Tsujinaka T, et al. Genetic polymorphisms of drug-metabolizing enzymes and susceptibility to head-and-neck squamous-cell carcinoma. Int J Cancer 1999; 80:685–8.

    Article  PubMed  CAS  Google Scholar 

  156. Park JY, Muscat JE, Ren Q, et al. CYP1A1 and GSTM1 polymorphisms and oral cancer risk. Cancer Epidemiol Biomarkers Prev 1997; 6:791–7.

    PubMed  CAS  Google Scholar 

  157. Tanimoto K, Hayashi S, Yoshiga K, Ichikawa T. Polymorphisms of the CYP1A1 and GSTM1 gene involved in oral squamous cell carcinoma in association with a cigarette dose. Oral Oncol 1999; 35:191–6.

    Article  PubMed  CAS  Google Scholar 

  158. Sato M, Sato T, Izumo T, Amagasa T. Genetic polymorphism of drug-metabolizing enzymes and susceptibility to oral cancer. Carcinogenesis 1999; 20:1927–31.

    Article  PubMed  CAS  Google Scholar 

  159. Hung HC, Chuang J, Chien YC, et al. Genetic polymorphisms of CYP2E1, GSTM1, and GSTT1; environmental factors and risk of oral cancer. Cancer Epidemiol Biomarkers Prev 1997; 6:901–5.

    PubMed  CAS  Google Scholar 

  160. Gonzalez MV, Alvarez V, Pello MF, Menendez MJ, Suarez C, Coto E. Genetic polymorphism of N-acetyltransferase-2, glutathione S-transferase-M1, and cytochromes P450IIE1 and P450IID6 in the susceptibility to head and neck cancer. J ClinPathol 1998; 51:294–8.

    CAS  Google Scholar 

  161. Ko Y, Abel J, Harth V, et al. Association of CYP1B1 codon 432 mutant allele in head and neck squamous cell cancer is reflected by somatic mutations of p53 in tumor tissue. Cancer Res 2001; 61:4398–404.

    PubMed  CAS  Google Scholar 

  162. Worrall SF, Corrigan M, High A, et al. Susceptibility and outcome in oral cancer: preliminary data showing an association with polymorphism in cytochrome P450 CYP2D6. Pharmacogenetics 1998; 8:433–9.

    PubMed  CAS  Google Scholar 

  163. Lafuente A, Pujol F, Carretero P, Villa JP, Cuchi A. Human glutathione S-transferase mu (GST mu) deficiency as a marker for the susceptibility to bladder and larynx cancer among smokers. Cancer Lett 1993; 68:49–54.

    Article  PubMed  CAS  Google Scholar 

  164. Trizna Z, Clayman GL, Spitz MR, Briggs KL, Goepfert H. Glutathione s-transferase genotypes as risk factors for head and neck cancer. Am J Surg 1995; 170:499–501.

    Article  PubMed  CAS  Google Scholar 

  165. Cheng L, Sturgis EM, Eicher SA, Char D, Spitz MR, Wei Q. Glutathione-Stransferase polymorphisms and risk of squamous-cell carcinoma of the head and neck, Int J Cancer 1999; 84:220–4.

    Article  PubMed  CAS  Google Scholar 

  166. Kihara M, Kubota A, Furukawa M, Kimura H. GSTM1 gene polymorphism as a possible marker for susceptibility to head and neck cancers among Japanese smokers. Cancer Lett 1997; 112:257–62.

    Article  PubMed  CAS  Google Scholar 

  167. Nomura T, Noma H, Shibahara T, Yokoyama A, Muramatusu T, Ohmori T. Aldehyde dehydrogenase 2 and glutathione S-transferase M 1 polymorphisms in relation to the risk for oral cancer in Japanese drinkers. Oral Oncol 2000; 36:42–6.

    Article  PubMed  CAS  Google Scholar 

  168. Deakin M, Elder J, Hendrickse C, et al. Glutathione S-transferase GSTT1 genotypes and susceptibility to cancer: studies of interactions with GSTM1 in lung, oral, gastric and colorectal cancers. Carcinogenesis 1996; 17:881–4.

    PubMed  CAS  Google Scholar 

  169. Jourenkova-Mironova N, Voho A, Bouchardy C, et al. Glutathione S-transferase GSTM1, GSTM3, GSTP1 and GSTT1 genotypes and the risk of smoking-related oral and pharyngeal cancers. Int J Cancer 1999; 81:44–8.

    Article  PubMed  CAS  Google Scholar 

  170. Park LY, Muscat JE, Kaur T, et al. Comparison of GSTM polymorphisms and risk for oral cancer between African-Americans and Caucasians. Pharmacogenetics 2000; 10:123–31.

    PubMed  CAS  Google Scholar 

  171. Matthias C, Bockmuhl U, Jahnke V, et al. The glutathione S-transferase GSTP1 polymorphism: effects on susceptibility to oral/pharyngeal and laryngeal carcinomas. Pharmacogenetics 1998; 8:1–6.

    PubMed  CAS  Google Scholar 

  172. Park JY, Schantz SP, Stern JC, Kaur T, Lazarus P. Association between glutathione S-transferase pi genetic polymorphisms and oral cancer risk. Pharmacogenetics 1999; 9:497–504.

    PubMed  CAS  Google Scholar 

  173. Katoh T, Kaneko S, Takasawa S, et al. Human glutathione S-transferase P1 polymorphism and susceptibility to smoking related epithelial cancer; oral, lung, gastric, colorectal and urothelial cancer. Pharmacogenetics 1999; 9:165–9.

    PubMed  CAS  Google Scholar 

  174. Jourenkova-Mironova N, Voho A, Bouchardy C, et al. Glutathione S-transferase GSTM3 and GSTP1 genotypes and larynx cancer risk. Cancer Epidemiol Biomarkers Prev 1999; 8:185–8.

    PubMed  CAS  Google Scholar 

  175. Lazarus P, Sheikh SN, Ren Q, et al. p53, but not p16 mutations in oral squamous cell carcinomas are associated with specific CYP1A1 and GSTM1 polymorphic genotypes and patient tobacco use. Carcinogenesis 1998; 19:509–14.

    Article  PubMed  CAS  Google Scholar 

  176. Bosron WF, Lumeng L, Li TK. Genetic polymorphism of enzymes of alcohol metabolism and susceptibility to alcoholic liver disease. Mol Aspects Med 1988; 10:147–58.

    PubMed  CAS  Google Scholar 

  177. Coutelle C, Ward PJ, Fleury B, et al. Laryngeal and oropharyngeal cancer, and alcohol dehydrogenase 3 and glutathione S-transferase Ml polymorphisms. Hum Genet 1997; 99:319–25.

    Article  PubMed  CAS  Google Scholar 

  178. Harty LC, Caporaso ME, Hayes RB, et al. Alcohol dehydrogenase 3 genotype and risk of oral cavity and pharyngeal cancers. J Natl Cancer Inst 1997; 89:1698–705.

    Article  PubMed  CAS  Google Scholar 

  179. Schwartz SM, Doody DR, Fitzgibbons ED, Ricks S, Porter PL, Chen C. Oral squamous cell cancer risk in relation to alcohol consumption and alcohol dehydrogenase-3 genotypes. Cancer Epidemiol Biomarkers Prev 2001; 10:1137–44.

    PubMed  CAS  Google Scholar 

  180. Olshan AF, Weissler MC, Watson MA, Bell DA. Risk of head and neck cancer and the alcohol dehydrogenase 3 genotype. Carcinogenesis 2001; 22:57–61.

    Article  PubMed  CAS  Google Scholar 

  181. Sturgis EM, Dahlstrom KR, Guan Y, et al. Alcohol dehydrogenase 3 genotype is not associated with risk of squamous cell carcinoma of the oral cavity and pharynx. Cancer Epidemiol Biomarkers Prev 2001; 10:273–5.

    PubMed  CAS  Google Scholar 

  182. Bouchardy C, Hirvonen A, Coutelle C, Ward PJ, Dayer P, Benhamou S. Role of alcohol dehydrogenase 3 and cytochrome P-4502E1 genotypes in susceptibility to cancers of the upper aerodigestive tract. Int J Cancer 2000; 87:734–40.

    Article  PubMed  CAS  Google Scholar 

  183. Yokoyama A, Muramatsu T, Omori T, et al. Alcohol and aldehyde dehydrogenase gene polymorphisms and oropharyngolaryngeal, esophageal and stomach cancers in Japanese alcoholics. Carcinogenesis 2001; 22:433–9.

    Article  PubMed  CAS  Google Scholar 

  184. Schantz SP, Zhang ZF, Spitz MS, Sun M, Hsu TC. Genetic susceptibility to head and neck cancer: interaction between nutrition and mutagen sensitivity. Laryngoscope 1997; 107:765–81.

    PubMed  CAS  Google Scholar 

  185. Cloos J, Spitz MR, Schantz SP, et al. Genetic susceptibility to head and neck squamous cell ai]carcinoma. J Natl Cancer Inst1996; 88:530–5.

    PubMed  CAS  Google Scholar 

  186. Zheng Y, Shen H, Sturgis EM, et al. Cyclin D1 polymorphism and risk for squamous cell carcinoma of the head and neck: a case-control study. Carcinogenesis 2001; 22:1195–9.

    PubMed  CAS  Google Scholar 

  187. Sturgis EM, Zheng R, Li L, et al. XPD/ERCC2 polymorphisms and risk of head and neck cancer: a case-control analysis. Carcinogenesis 2000; 21:2219–23.

    Article  PubMed  CAS  Google Scholar 

  188. Slaughter DP, Southwick HW, Smejkal W. “Filed cancerization” in oral stratified squamous epithelium: clinical implications of multicentric origin. Cancer 1953; 6:963–8.

    PubMed  CAS  Google Scholar 

  189. Licciardello JT, Spitz MR, Hong WK. Multiple primary cancer in patients with cancer of the head and neck: second cancer of the head and neck, esophagus, and lung. Int J Radiat Oncol Biol Phys 1989; 17:467–76.

    PubMed  CAS  Google Scholar 

  190. Erkal HS, Mendenhall WM, Amdur RJ, Villaret DB, Stringer SP. Synchronous and metachronous squamous cell carcinomas of the head and neck mucosal sites. J Clin Oncol 2001; 19:1358–62.

    PubMed  CAS  Google Scholar 

  191. Jones AS, Morar P, Phillips DE, Field JK, Husband D, Helliwell TR. Second primary tumors in patients with head and neck squamous cell carcinoma. Cancer 1995; 75:1343–53.

    PubMed  CAS  Google Scholar 

  192. Fijuth J, Mazeron JJ, Le Pechoux C, et al. Second head and neck cancers following radiation therapy of T1 and T2 cancers of the oral cavity and oropharynx. Int J Radiat Oncol Biol Phys 1992; 24:59–64.

    PubMed  CAS  Google Scholar 

  193. Cooper JS, Pajak TF, Rubin P, et al. Second malignancies in patients who have head and neck cancer: incidence, effect on survival and implications based on the RTOG experience, hit J Radiat Oncol Biol Phys 1989; 17:449–56.

    CAS  Google Scholar 

  194. Roberts TJ, Epstein B, Lee DJ. Second neoplasms in patients with carcinomas of the vocal cord: incidence and implications for survival. Int J Radiat Oncol Biol Phys 1991; 21:583–9.

    PubMed  CAS  Google Scholar 

  195. Schwartz LH, Ozsahin M, Zhang GN, et al. Synchronous and metachronous head and neck carcinomas. Cancer 1994; 74:1933–8.

    PubMed  CAS  Google Scholar 

  196. Cooper JS, Scott C, Marcial V, et al. The relationship of nasopharyngeal carcinomas and second independent malignancies based on the Radiation Therapy Oncology Group experience. Cancer 1991; 67:1673–7.

    PubMed  CAS  Google Scholar 

  197. Wang CC, Chen ML, Hsu KH, et al. Second malignant tumors in patients with nasopharyngeal carcinoma and their association with Epstein-Barr virus, Int J Cancer 2000; 87:228–31.

    Article  PubMed  CAS  Google Scholar 

  198. Cianfriglia F, Di Gregorio DA, Manieri A. Multiple primary tumours in patients with oral squamous cell carcinoma. Oral Oncol 1999; 35:157–63.

    Article  PubMed  CAS  Google Scholar 

  199. Day GL, Blot WJ, Shore RE, et al. Second cancers following oral and pharyngeal cancer: patients’ characteristics and survival patterns. Eur J Cancer B Oral Oncol 1994; 30B:381–6.

    PubMed  CAS  Google Scholar 

  200. Khun FR, Kim ES, Lee JJ, et al. The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head 10:823–9.

    Google Scholar 

  201. Leong PP, Rezai B, Koch WM, et al. Distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma. J Natl Cancer Inst1998; 90:972–7.

    Article  PubMed  CAS  Google Scholar 

  202. Vikram B. Changing patterns of failure in advanced head and neck cancer. Arch Otolaryngol 1984; 110:564–5.

    PubMed  CAS  Google Scholar 

  203. Guggenheimer J, Verbin RS, Johnson JT, Horkowitz CA, Myers EN. Factors delaying the diagnosis of oral and oropharyngeal carcinomas. Cancer 1989; 64:932–5.

    PubMed  CAS  Google Scholar 

  204. Mackie AM, Epstein JB, Wu JS, Stevenson-Moore P. Nasopharyngeal carcinoma: the role of the dentist in assessment, early diagnosis and care before and after cancer therapy. Oral Oncol 2000; 36:397–403.

    Article  PubMed  CAS  Google Scholar 

  205. Black RJ, Gluckman JL, Shumrick DA. Screening for distant metastases in head and neck cancer patients. Aust N Z J Surg 1984; 54:527–30.

    PubMed  CAS  Google Scholar 

  206. Reiner B, Siegel E, Sawyer R, Brocato RM, Maroney M, Hooper F. The impact of routine CT of the chest on the diagnosis and management of newly diagnosed squamous cell carcinoma of the head and neck. AJR Am J Roentgenol 1997; 169:667–71.

    PubMed  CAS  Google Scholar 

  207. de Bree R, Deurloo EE, Snow GB, Leemans CR. Screening for distant metastases in patients with head and neck cancer. Laryngoscope 2000; 110:397–401.

    PubMed  Google Scholar 

  208. Halpem J. The value of chest CT scan in the work-up of head and neck cancers. J Med 1997; 28:191–8.

    Google Scholar 

  209. Hong WK, Bromer RH, Amato DA, et al. Patterns of relapse in locally advanced head and neck cancer patients who achieved complete remission after combined modality therapy. Cancer 1985; 56:1242–5.

    PubMed  CAS  Google Scholar 

  210. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. The Department of Veterans Affairs Laryngeal Cancer Study Group. N Engl J Med 1991; 324:1685–90.

    Google Scholar 

  211. Lefebvre JL, Chevalier D, Luboinski B, Kirkpatrick A, Collette L, Sahmoud T. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst 1996; 88:890–9.

    PubMed  CAS  Google Scholar 

  212. Leibel SA, Scott CB, Mohiuddin M, et al. The effect of local-regional control on distant metastatic dissemination in carcinoma of the head and neck: results of an analysis from the RTOG head and neck database. Int J Radiat Oncol Biol Phys 1991; 21:549–56.

    PubMed  CAS  Google Scholar 

  213. Calhoun KH, Fulmer P, Weiss R, Hokanson JA. Distant metastases from head and neck squamous cell carcinomas. Laryngoscope 1994; 104:1199–205.

    PubMed  CAS  Google Scholar 

  214. Johnson JT. Proposal of standardization on screening tests for detection of distant metastases from head and neck cancer. ORL J Otorhinolaryngol Relat Spec 2001; 63:256–8.

    PubMed  CAS  Google Scholar 

  215. Houghton DJ, Hughes ML, Garvey C, et al. Role of chest CT scanning in the management of patients presenting with head and neck cancer. Head Neck 1998; 20:614–8.

    Article  PubMed  CAS  Google Scholar 

  216. Houghton DJ, McGarry G, Stewart I, Wilson JA, MacKenzie K. Chest computerized tomography scanning in patients presenting with head and neck cancer. Clin Otolaryngol 1998; 23:348–50.

    PubMed  CAS  Google Scholar 

  217. Mercader VP, Gatenby RA, Mohr RM, Fisher MS, Caroline DF. CT surveillance of the thorax in patients with squamous cell carcinoma of the head and neck: a preliminary experience. J Comput Assist Tomogr 1997; 21:412–7.

    Article  PubMed  CAS  Google Scholar 

  218. Martin GF, Gullane PJ, Heeneman H. Radionuclide scans in the assessment of distant metastases from squamous cell carcinoma of the head and neck. J Otolaryngol 1981; 10:383–6.

    PubMed  CAS  Google Scholar 

  219. Lindberg R. Distribution of cervical lymph node metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer 1972; 29:1446–9.

    PubMed  CAS  Google Scholar 

  220. Laubenbacher C, Saumweber D, Wagner-Manslau C, et al. Comparison of fluorine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous-cell carcinomas. J Nucl Med 1995; 36:1747–57.

    PubMed  CAS  Google Scholar 

  221. Adams S, Baum RP, Stuckensen T, Bitter K, Hor G. Prospective comparison of 18FFDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer. Eur J Nucl Med 1998; 25:1255–60.

    PubMed  CAS  Google Scholar 

  222. Myers LL, Wax MK, Nabi H, Simpson GT, Lamonica D. Positron emission tomography in the evaluation of the N0 neck. Laryngoscope 1998; 108:232–6.

    PubMed  CAS  Google Scholar 

  223. Stuckensen T, Kovacs AF, Adams S, Baum RP. Staging of the neck in patients with oral cavity squamous cell carcinomas: a prospective comparison of PET, ultrasound, CT and MRI. J Craniomaxillofac Surg 2000; 28:319–24.

    PubMed  CAS  Google Scholar 

  224. Mendenhall WM, Mancuso AA, Parsons JT, Stringer SP, Cassisi NJ. Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary site. Head Neck 1998; 20:739–44.

    Article  PubMed  CAS  Google Scholar 

  225. Bohuslavizki KH, Klutmann S, Kroger S, et al. FDG PET detection of unknown primary tumors. J Nucl Med 2000; 41:816–22.

    PubMed  CAS  Google Scholar 

  226. Safa AA, Tran LM, Rege S, et al. The role of positron emission tomography in occult primary head and neck cancers. Cancer J Sci Am 1999; 5:214–8.

    PubMed  CAS  Google Scholar 

  227. Jungehulsing M, Scheidhauer K, Damm M, et al. 2[F]-fluoro-2-deoxy-D-glucose positron emission tomography is a sensitive tool for the detection of occult primary cancer (carcinoma of unknown primary syndrome) with head and neck lymph node manifestation. Otolaryngol Head Neck Surg 2000; 123:294–301.

    PubMed  CAS  Google Scholar 

  228. Hanasono MM, Kunda LD, Segall GM, Ku GH, Terris DJ. Uses and limitations of FDG positron emission tomography in patients with head and neck cancer. Laryngoscope 1999; 109:880–5.

    PubMed  CAS  Google Scholar 

  229. Greven KM, Keyes JW, Jr., Williams DW, 3rd, McGuirt WF, Joyce WT, 3rd. Occult primary tumors of the head and neck: lack of benefit from positron emission tomography imaging with 2-[F-18]fluoro-2-deoxy-D-glucose. Cancer 1999; 86:114–8.

    Article  PubMed  CAS  Google Scholar 

  230. Keyes JW, Jr., Chen MY, Watson NE, Jr., Greven KM, McGuirt WF, Williams DW, 3rd. FDG PET evaluation of head and neck cancer: value of imaging the thorax. Head Neck 2000; 22:105–10.

    Article  PubMed  Google Scholar 

  231. Lonneux M, Lawson G, Ide C, Bausart R, Remacle M, Pauwels S. Positron emission tomography with fluorodeoxyglucose for suspected head and neck tumor recurrence in the symptomatic patient. Laryngoscope 2000; 110:1493–7.

    PubMed  CAS  Google Scholar 

  232. Kitagawa Y, Sadato N, Azuma H, et al. FDG PET to evaluate combined intra-arterial chemotherapy and radiotherapy of head and neck neoplasms. J Nucl Med 1999; 40:1132–7.

    PubMed  CAS  Google Scholar 

  233. Farber LA, Benard F, Machtay M, et al. Detection of recurrent head and neck squamous cell carcinomas after radiation therapy with 2-18F-fluoro-2-deoxy-Dglucose positron emission tomography. Laryngoscope 1999; 109:970–5.

    PubMed  CAS  Google Scholar 

  234. Stokkel MP, Terhaard CH, Hordijk GJ, van Rijk PP. The detection of local recurrent head and neck cancer with fluorine-18 fluorodeoxyglucose dual-head positron emission tomography. Eur J Nucl Med 1999; 26:767–73.

    PubMed  CAS  Google Scholar 

  235. Anzai Y, Carroll WR, Quint DJ, et al. Recurrence of head and neck cancer after surgery or irradiation: prospective comparison of 2-deoxy-2-[F-18]fluoro-D-glucose PET and MR imaging diagnoses. Radiology 1996; 200:135–41.

    PubMed  CAS  Google Scholar 

  236. Charron M, Beyer T, Bohnen NN, et al. Image analysis in patients with cancer studied with a combined PET and CT scanner. Clin Nucl Med 2000; 25:905–10.

    PubMed  CAS  Google Scholar 

  237. Knappe M, Louw M, Gregor RT. Ultrasonography-guided fine-needle aspiration for the assessment of cervical metastases. Arch Otolaryngol Head Neck Surg 2000; 126:1091–6.

    PubMed  CAS  Google Scholar 

  238. Righi PD, Kopecky KK, Caldemeyer KS, Ball VA, Weisberger EC, Radpour S. Comparison of ultrasound-fine needle aspiration and computed tomography in patients undergoing elective neck dissection. Head Neck 1997; 19:604–10.

    Article  PubMed  CAS  Google Scholar 

  239. van den Brekel MW, Castelijns JA, Stel HV, Golding RP, Meyer CJ, Snow GB. Modern imaging techniques and ultrasound-guided aspiration cytology for the assessment of neck node metastases: a prospective comparative study. Eur Arch Otorhinolaryngol 1993; 250:11–7.

    Article  PubMed  Google Scholar 

  240. Takes RP, Knegt P, Manni JJ, et al. Regional metastasis in head and neck squamous cell carcinoma: revised value of US with US-guided FNAB. Radiology 1996; 198:819–23.

    PubMed  CAS  Google Scholar 

  241. van den Brekel MW. US-guided fine-needle aspiration cytology of neck nodes in patients with N0 disease. Radiology 1996; 201:580–1.

    PubMed  Google Scholar 

  242. Atula TS, Varpula MJ, Kurki TJ, Klemi PJ, Grenman R. Assessment of cervical lymph node status in head and neck cancer patients: palpation, computed tomography and low field magnetic resonance imaging compared with ultrasound-guided fineneedle aspiration cytology. Eur J Radiol 1997; 25:152–61.

    Article  PubMed  CAS  Google Scholar 

  243. van den Brekel MW. Lymph node metastases: CT and MRI. Eur J Radiol 2000; 33:230–8.

    PubMed  Google Scholar 

  244. Cortesina G, Gabriele P, Giordano C, et al. Report of an international workshop on perspectives on secondary prevention of laryngeal cancer. Eur J Cancer 1993; 9:1348–52.

    Google Scholar 

  245. Sankaranarayanan R, Mathew B, Jacob BJ, et al. Early findings from a community-based, cluster-randomized, controlled oral cancer screening trial in Kerala, India. The Trivandrum Oral Cancer Screening Study Group. Cancer 2000; 88:664–73.

    Article  PubMed  CAS  Google Scholar 

  246. Mehta FS, Gupta PC, Bhonsle RB, Murti PR, Daftary DK, Pindborg JJ. Detection of oral cancer using basic health workers in an area of high oral cancer incidence in India. Cancer Detect Prev 1986; 9:219–25.

    PubMed  CAS  Google Scholar 

  247. Warnakulasuriya KA, Nanayakkara BG. Reproducibility of an oral cancer and precancer detection program using a primary health care model in Sri Lanka. Cancer Detect Prev 1991; 15:331–4.

    PubMed  CAS  Google Scholar 

  248. Ikeda N, Ishii T, Iida S, Kawai T. Epidemiological study of oral leukoplakia based on mass screening for oral mucosal diseases in a selected Japanese population. Community Dent Oral Epidemiol 1991; 19:160–3.

    PubMed  CAS  Google Scholar 

  249. Ikeda N, Downer MC, Ozowa Y, Inoue C, Mizuno T, Kawai T. Characteristics of participants and non-participants in annual mass screening for oral cancer in 60-year-old residents of Tokoname city, Japan. Community Dent Health 1995; 12:83–8.

    PubMed  CAS  Google Scholar 

  250. Nagao T, Warnakulasuriya S, Ikeda N, Fukano H, Fujiwara K, Miyazaki H. Oral cancer screening as an integral part of general health screening in Tokoname City, Japan. J Med Screen 2000; 7:203–8.

    Article  PubMed  CAS  Google Scholar 

  251. Downer MC, Evans AW, Hughes Hallet CM, Jullien JA, Speight PM, Zakrzewska JM. Evaluation of screening for oral cancer and precancer in a company headquarters. Community Dent Oral Epidemiol 1995; 23:84–8.

    PubMed  CAS  Google Scholar 

  252. Jullien JA, Downer MC, Zakrzewska JM, Speight PM. Evaluation of a screening test for the early detection of oral cancer and precancer. Community Dent Health 1995; 12:3–7.

    PubMed  CAS  Google Scholar 

  253. Field EA, Morrison T, Darling AE, Parr TA, Zakrzewska JM. Oral mucosal screening as an integral part of routine dental care. BrDent J 1995; 179:262–6.

    CAS  Google Scholar 

  254. Talamini R, Barzan L, Franceschi S, Caruso G, Gasparin A, Comoretto R. Determinants of compliance with an early detection programme for cancer of the head and neck in north-eastern Italy. Eur J Cancer B Oral Oncol 1994; 30B:415–8.

    PubMed  CAS  Google Scholar 

  255. Banoczy J, Rigo O. Prevalence study of oral precancerous lesions within a complex screening system in Hungary. Community Dent Oral Epidemiol 1991; 19:265–7.

    PubMed  CAS  Google Scholar 

  256. Axell T. Occurrence of leukoplakia and some other oral white lesions among 20,333 adult Swedish people. Community Dent Oral Epidemiol 1987; 15:46–51.

    PubMed  CAS  Google Scholar 

  257. Bouquot JE, Gorlin RJ. Leukoplakia, lichen planus, and other oral keratoses in 23,616 white Americans over the age of 35 years. Oral Surg Oral Med Oral Pathol 1986; 61:373–81.

    PubMed  CAS  Google Scholar 

  258. Frenandez Garrote L, Sankaranarayanan R, Lence Anta JJ, Rodriguez Salva A, Maxwell Parkin D. An evaluation of the oral cancer control program in Cuba. epidemiology 1995; 6:428–31.

    PubMed  CAS  Google Scholar 

  259. Hawkins RJ, Wang EE, Leake JL. Preventive health care, 1999 update: prevention of oral cancer mortality. The Canadian Task Force on Preventive Health Care. J Can dent Assoc 1999; 65:617.

    PubMed  CAS  Google Scholar 

  260. Santana JC, Delgado L, Miranda J, Sanchez M. Oral Cancer Case Finding Program (OCCFP). Oral Oncol 1997; 33:10–2.

    PubMed  CAS  Google Scholar 

  261. Rosenberg D, Cretin S. Use of meta-analysis to evaluate tolonium chloride in oral Cancer screening. Oral Surg Oral Med Oral Pathol 1989; 67:621–7.

    Article  PubMed  CAS  Google Scholar 

  262. Leipzig B, Zellmer JE, Klug D. The role of endoscopy in evaluating patients with head and neck cancer. A multi-institutional prospective study. Arch Otolaryngol 1985; 111:589–94.

    PubMed  CAS  Google Scholar 

  263. Epstein JB, Oakley C, Millner A, Emerton S, van der Meij E, Le N. The utility of toluidine blue application as a diagnostic aid in patients previously treated for upper oropharyngeal carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997; 83:537–47.

    PubMed  CAS  Google Scholar 

  264. Franceschi S, Barzan L, Talamini R. Screening for cancer of the head and neck: if not now, when? Oral Oncol 1997; 33:313–6.

    Article  PubMed  CAS  Google Scholar 

  265. Smith RA, Mettlin CJ, Davis KJ, Eyre H. American Cancer Society guidelines for the early detection of cancer. CA Cancer J Clin 2000; 50:34–49.

    PubMed  CAS  Google Scholar 

  266. Screening for oral cancer. U.S. Preventive Task Force. Guide to Clinical Preventive Services 1996.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Northwestern University Medical School and the Robert H. Lurie Comprehensive Cancer Center, Chicago, Illinois

    Athanassios Argiris M.D.

  2. Division of Hematology/Oncology, The University of Chicago, Chicago, Illinois

    Cathy Eng M.D. (Fellow)

Authors
  1. Athanassios Argiris M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Cathy Eng M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Evanston Northwestern Healthcare, Evanston, IL

    Brockstein Bruce M.D.  & Masters Gregory M.D.  & 

  2. Robert H. Lurie Cancer Center of Northwestern University, Feinberg School of Medicine, Chicago, IL

    Brockstein Bruce M.D.  & Masters Gregory M.D.  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Kluwer Academic Publishers

About this chapter

Cite this chapter

Argiris, A., Eng, C. (2004). Epidemiology, Staging, and Screening of Head and Neck Cancer. In: Bruce, B., Gregory, M. (eds) Head and Neck Cancer. Cancer Treatment and Research, vol 114. Springer, Boston, MA. https://doi.org/10.1007/0-306-48060-3_2

Download citation

  • DOI: https://doi.org/10.1007/0-306-48060-3_2

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4020-7336-6

  • Online ISBN: 978-0-306-48060-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation